A new chapter for growth and value creation by innovation
Returning to a private company structure marks a key milestone in HeiQ’s evolution. Since its listing on the London Stock Exchange in December 2020, the company has expanded into four new technology platforms, including precision fermentation, cellulosic fiber extrusion, particle synthesis, and chemical vapour deposition. Today, besides operating as an innovative leader for the textile industry, HeiQ functions as a venture incubator, advancing several high-potential technologies at various stages of technology readiness.
Rationale for returning to private ownership
The unanimous decision by HeiQ’s board to return to being a privately held company from the London Stock Exchange aligns with the company’s focus on innovation, long-term growth and value creation. As HeiQ continues to develop advanced technologies, private financing offers more flexibility to invest into the value creation of its high-potential ventures like HeiQ Synbio, HeiQ AeoniQ™, HeiQ GrapheneX, and HeiQ Xpectra.
“Our four years as a public company have seen us acquire four companies and change from a yield focused speciality chemicals player with a narrow textile focus to a multi technology platform innovation incubator with diversified market channels and long-term value creation opportunities. Returning to private company status will enable us to better focus on scaling and financing innovation and technology,” said Carlo Centonze, Co-Founder and Group CEO of HeiQ. “With game-changing ventures like HeiQ Synbio, HeiQ AeoniQ™, HeiQ GrapheneX, and HeiQ Xpectra, we are well-positioned to seize emerging opportunities and achieve our value creation and sustainability goals.”
Commitment to core businesses
HeiQ remains dedicated to its commercialized core business of value-adding textile technologies and synbiotics for cleaning and personal care. With a solid foundation in these areas, HeiQ will continue to deliver advanced innovations that enhance sustainability, durability, and functionality of our everyday products. HeiQ’s global partnerships in textile finishing remain a vital part of its strategy, as the company leads the way in solutions that benefit industries and consumers worldwide. Alongside textile innovations, HeiQ's unique synbiotic technology platform provides advanced solutions in cleaning and personal care, supporting microbial balance on surfaces and on skin.
Support for shareholders and stakeholders
HeiQ remains committed to transparency and engagement with its shareholders. HeiQ’s shares will be available for trading on the JP Jenkins securities or similar matching platform starting on November 20, 2024.
Returning to a private company structure marks a key milestone in HeiQ’s evolution. Since its listing on the London Stock Exchange in December 2020, the company has expanded into four new technology platforms, including precision fermentation, cellulosic fiber extrusion, particle synthesis, and chemical vapour deposition. Today, besides operating as an innovative leader for the textile industry, HeiQ functions as a venture incubator, advancing several high-potential technologies at various stages of technology readiness.
Rationale for returning to private ownership
The unanimous decision by HeiQ’s board to return to being a privately held company from the London Stock Exchange aligns with the company’s focus on innovation, long-term growth and value creation. As HeiQ continues to develop advanced technologies, private financing offers more flexibility to invest into the value creation of its high-potential ventures like HeiQ Synbio, HeiQ AeoniQ™, HeiQ GrapheneX, and HeiQ Xpectra.
“Our four years as a public company have seen us acquire four companies and change from a yield focused speciality chemicals player with a narrow textile focus to a multi technology platform innovation incubator with diversified market channels and long-term value creation opportunities. Returning to private company status will enable us to better focus on scaling and financing innovation and technology,” said Carlo Centonze, Co-Founder and Group CEO of HeiQ. “With game-changing ventures like HeiQ Synbio, HeiQ AeoniQ™, HeiQ GrapheneX, and HeiQ Xpectra, we are well-positioned to seize emerging opportunities and achieve our value creation and sustainability goals.”
Commitment to core businesses
HeiQ remains dedicated to its commercialized core business of value-adding textile technologies and synbiotics for cleaning and personal care. With a solid foundation in these areas, HeiQ will continue to deliver advanced innovations that enhance sustainability, durability, and functionality of our everyday products. HeiQ’s global partnerships in textile finishing remain a vital part of its strategy, as the company leads the way in solutions that benefit industries and consumers worldwide. Alongside textile innovations, HeiQ's unique synbiotic technology platform provides advanced solutions in cleaning and personal care, supporting microbial balance on surfaces and on skin.
Support for shareholders and stakeholders
HeiQ remains committed to transparency and engagement with its shareholders. HeiQ’s shares will be available for trading on the JP Jenkins securities or similar matching platform starting on November 20, 2024.
